Loretta Swit Dies: The ‘M*A*S*H' Emmy Award Winner Was 87
Born November 4, 1937 in Passaic, New Jersey, Loretta Swit began her career as an actress Off-Broadway in the Actor's Playhouse production of An Enemy of the People. In 1961, Swit landed a role in the Circle in the Square production of The Balcony and later toured with the national company of Ash Wednesday. Additionally, she played on of the Pidgeon sisters in the theater in The Odd Couple, among other roles on stage.
Prior to M*A*S*H, Swit's early roles on television included episodes of Hawaii Five-O, Mannix, Mission: Impossible, Gunsmoke and Bonanza. In 1972 came M*A*S*H, which ultimately changed her career but started out slowly. After a low-rated inaugural season, CBS moved M*A*S*H to the cushy Saturday 8:30 p.m. time period out of the then top-rated show in primetime, All in the Family, and into The Mary Tyler Moore Show. M*A*S*H only aired on Saturday one season, but was able to stand on its own by season three. It ran for 11 seasons, rising to No. 3 over in that final season.
During her tenure M*A*S*H, Swit acted in other projects, including films Freebie and the Bean (1974) and Race With the Devil (1975) and BoardHeads (1998), but perhaps her greatest acting achievement was as the original Christine Cagney opposite Tyne Daly as Mary Beth Lacey in the 1981 TV movie/pilot for Cagney & Lacey. Swit was interested in continuing in the series, but was contracted to M*A*S*H. After Meg Foster played Cagney in the six-episode abbreviated first season, Sharon Gless took over the role.
Swit's other film roles included agent Polly Reed in Blake Edwards' satire of Hollywood in S.O.B. in 1981 and Play the Flute, her final role, in 2019.
Swit was also an animal activist, serving on the boards of Actors and Others for Animals and The Wildlife Waystation and as a spokesperson for the Humane Society. In 2016, she founded SwitHeart Animal Alliance, a nonprofit dedicated to ending animal cruelty.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
RPMG Welcomes Dr. James Weinberger and Launches Center for Male Fertility
LOS ANGELES, August 04, 2025--(BUSINESS WIRE)--Reproductive Partners Medical Group (RPMG), trusted leader in advanced fertility care and member of the Ivy Fertility network, is proud to announce the September 2025 launch of its new Center for Male Fertility, led by fellowship-trained reproductive urologist Dr. James Weinberger. As the Center's Director, Dr. Weinberger brings deep expertise in male reproductive health and a commitment to providing men with the same high level of care and clarity that RPMG is known for. "Fertility is a shared journey, and male fertility deserves just as much care and attention," said Dr. Weinberger. "Our goal is to offer answers and options in a space that's supportive, cutting-edge and designed specifically for men." Built to meet a growing need in reproductive medicine, the Center for Male Fertility provides men with a dedicated, compassionate space to understand and optimize their reproductive health. Services will include semen analysis, hormone evaluation and optimization, microsurgical sperm retrieval (mTESE), varicocelectomy, vasectomy reversal, and consultative support for couples undergoing IVF or ICSI. As one of just 2% of urologists in the U.S. fellowship-trained in male infertility microsurgery, Dr. Weinberger brings a level of precision and expertise that directly impacts outcomes. His advanced training ensures that men at RPMG receive care that goes beyond the standard. "Men are ready to be part of the fertility conversation. They just need a place to start," said Christina Westbrook, COO/CNO of RPMG. "This Center is about access and shifting how we support the full family-building journey." Referrals are now being accepted, and patients can schedule a consultation at About Reproductive Partners Medical Group With over 30 years of experience, Reproductive Partners Medical Group (RPMG) is known for delivering evidence-based fertility care. As part of the Ivy Fertility network, a globally respected leader in reproductive medicine, RPMG offers advanced treatments including IVF, IUI, third-party reproduction, and fertility preservation. The practice proudly serves all individuals and families, providing inclusive, expert care regardless of marital status, gender identity, or sexual orientation. About Ivy Fertility Ivy Fertility is globally recognized as pioneers and innovators in the field of advanced reproductive technologies, in-vitro fertilization, third-party reproduction, andrology, and fertility research. The Ivy Fertility network includes Dallas IVF, Fertility Associates of Memphis, Fertility Centers of Orange County, Idaho Fertility Center, IVF Fertility Center, Los Angeles Reproductive Center, Nevada Center for Reproductive Medicine, Nevada Fertility Center, Northern California Fertility Medical Center, NOVA IVF, Pacific Northwest Fertility, Reproductive Partners Medical Group, San Diego Fertility Center, Utah Fertility Center, and Virginia Fertility & IVF. By developing new procedures, achieving scientific breakthroughs, and teaching the latest techniques, Ivy Fertility upholds its commitment to successful outcomes and continually contributes to the development of the entire fertility community. The Ivy team is passionate about its family-building mission and works tirelessly each day to help patients become parents. View source version on Contacts Sara Zuboff, MBA, Marketing ManagerReproductive Partners Medical Groupszuboff@ | (310) 855-2229
Gizmodo
20 minutes ago
- Gizmodo
Dental Floss Could Deliver Next-Gen Vaccines, No Needles Required
Flu shot season is around the corner, and while injections remain the most common form of vaccination, scientists are working hard to find other ways to deliver inoculations that don't involve shoving a needle into your flesh. And in a new study, researchers think they might have found another novel approach: dental floss. In the new work, a team of scientists based in the U.S. demonstrated how this might work on lab mice, finding that vaccine delivery via dental floss was more effective at stimulating antibody production than if the vaccine was delivered under the mice's tongues and about as effective as a nasal spray delivery method. If the results hold true for humans, then some vaccines could be given via tooth tape and without the need for needles. 'Here we show that flat tape dental floss can deliver vaccines through the junctional epithelium of the gingival sulcus, exploiting its naturally leaky properties,' the researchers wrote in the study, which was published in July in the journal Nature Biomedical Engineering. The junctional epithelium is the technical term for the deep tissue between the tooth and the gum. Epithelial tissues are one of three layers of so-called mucosal surfaces, which are the membranes that lubricate and protect your body's organs and cavities, including your nose, mouth, and intestines. Many pathogens like influenza and Covid-19 can enter the body through these mucosal surfaces. 'If a vaccine is given by injection, antibodies are primarily produced in the bloodstream throughout the body, and relatively few antibodies are produced on mucosal surfaces,' Harvinder Singh Gill, co-author of the study and a professor in Nanomedicine at North Carolina State University, explained in a statement. 'But we know that when a vaccine is given via the mucosal surface, antibodies are stimulated not only in the bloodstream, but also on mucosal surfaces.' 'This improves the body's ability to prevent infection, because there is an additional line of antibody defense before a pathogen enters the body,' he added. Because the tissue in between our teeth and gums is more permeable than other similar tissues, like those lining your stomach, lungs, and intestines, then it should be able to introduce a vaccine into the body relatively easily, triggering the production of antibodies throughout the mucosal layers. To test this idea, the researchers applied peptide flu vaccine on unwaxed dental floss, and then used it to floss the teeth of lab mice. Gill and colleagues then compared the animals' antibody production to that of mice that either received the peptide flu vaccine via a nasal spray or under their tongues. The dental floss vaccine delivered significantly superior antibody production on mucosal surfaces than the under-the-tongue inoculation, and was comparable to the nasal spray. 'This is extremely promising, because most vaccine formulations cannot be given via the nasal epithelium—the barrier features in that mucosal surface prevent efficient uptake of the vaccine,' said Gill, adding that nasal delivery also carries the risk of the vaccine reaching the brain, which could pose safety concerns. 'Vaccination via the junctional epithelium offers no such risk,' he said. The team also tested the floss approach with three other vaccine classes—proteins, inactivated viruses, and mRNA—and revealed that the novel method triggered antibodies both in the bloodstream and mucosal surfaces in all of them. What's more, their efficacy wasn't impeded if the mice consumed food or water right after flossing. To investigate the practicality of the flossing approach, the researchers also tested its mechanics with humans. Using floss picks, they coated the tape with food dye and asked study participants to try and get it as deep between their teeth and their gums as they could. Participants were able to deposit around 60% of the dye in the gum pocket, indicating that vaccine-coated floss picks could be an effective way to deliver vaccines to that tissue. As for costs, the researchers think that it would be similar in price to other vaccine delivery techniques. However, there are some inherent limitations to a floss vaccine. 'For example, it can only be used for individuals with teeth,' the researchers explained in the study. 'Therefore, this approach cannot be used in neonates [newborns] until they experience teeth eruption, which typically occurs at around 6 months of age. Further, the impact of gingival tissue infection on vaccination is unclear. Additional studies are required to answer this question.'
Fox News
21 minutes ago
- Fox News
Brand new NFL Hall of Famer has wardrobe malfunction doing signature sack celebration
Jared Allen did not disappoint on stage in Canton over the weekend. The former NFL star took the stage at the Pro Football Hall of Fame on Saturday to be officially inducted into the Pro Football Hall of Fame. Allen was a part of the class that also included Sterling Sharpe, Eric Allen, and Antonio Gates. Well, after he received his brand-new gold jacket, he wanted to turn back the clock and do his signature sack celebration. Unfortunately for Allen, suit pants don't have as much give as football pants. When Allen stood up, he realized that he had a major rip on the back of his pants, stretching from his rear all the way to near the kneecap. The 2004 fourth-round pick played for four teams in his 12-year career, most notably the Minnesota Vikings, in which he racked up four All-Pros, five Pro Bowls and 136 sacks. He twice led the NFL in sacks (2007 and 2011), and he also holds the records for most safeties in a career (four) and a season (two). Allen retired in 2015 after stints with the Chiefs, Vikings, Bears and Panthers. He lost the Super Bowl in his final season to the Denver Broncos in what wound up being Peyton Manning's final game.
